Skip to main content

The ESMO Congress is a globally influential platform in oncology for clinicians, researchers, patient advocates, journalists, and healthcare industry representatives from around the world. ESMO 2024 will disseminate the most advanced data, offer high-quality education, and excellent networking opportunities for oncologists and other stakeholders from around the world. At Roche, we are participating in this congress with a OneOnco approach, where together we aim to drive further innovation in oncology. 

CME available Oncologia Oftalmologia

Friday, 13 September 2024 - Tuesday, 17 September 2024

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam euismod, felis id vulputate mollis, erat nunc volutpat felis, eget mollis ipsum mauris ut erat. Praesent faucibus ac augue faucibus maximus. Quisque sagittis massa ante, vitae accumsan sapien tincidunt non. Aenean porta ante nec massa maximus pulvinar. Fusce in urna rutrum velit tincidunt tincidunt quis vel nunc. Quisque nisi dui, imperdiet ut cursus nec, interdum ac justo. Proin ac congue est.

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam euismod, felis id vulputate mollis, erat nunc volutpat felis, eget mollis ipsum mauris ut erat. Praesent faucibus ac augue faucibus maximus. Quisque sagittis massa ante, vitae accumsan sapien tincidunt non. Aenean porta ante nec massa maximus pulvinar. Fusce in urna rutrum velit tincidunt tincidunt quis vel nunc. Quisque nisi dui, imperdiet ut cursus nec, interdum ac justo. Proin ac congue est.

Agenda

9.30pm

Greeting

11.00am

  • Election sessions #3 (click on agenda item for more info)
  • Communication strategies for patients with different cultural and linguistic backgrounds (Dr. Ay)
  • Liquid Biopsy as Follow-Up - Ready for Primetime? (Prof. Loges + Prof. Bleckmann)
  • The basics of immunotherapy and the relevance for thoracic surgery (Prof. Passlick + Prof. Reinmuth)
  • A Discourse: Surgery and Systemic Therapy - Which Comes First? (Dr Welcker + Prof Hackanson)
  • Cancer Immunotherapy and Radiation - Additive or Toxic? (Prof. Rieken + PD Dr. Christoph)
  • Patient care in person versus digital - enrichment or competition? (Dr. Welslau + PD Dr. Fuchs)

9.30pm

Greeting

11.00am

  • Election sessions #3 (click on agenda item for more info)
  • Communication strategies for patients with different cultural and linguistic backgrounds (Dr. Ay)
  • Liquid Biopsy as Follow-Up - Ready for Primetime? (Prof. Loges + Prof. Bleckmann)
  • The basics of immunotherapy and the relevance for thoracic surgery (Prof. Passlick + Prof. Reinmuth)
  • A Discourse: Surgery and Systemic Therapy - Which Comes First? (Dr Welcker + Prof Hackanson)
  • Cancer Immunotherapy and Radiation - Additive or Toxic? (Prof. Rieken + PD Dr. Christoph)
  • Patient care in person versus digital - enrichment or competition? (Dr. Welslau + PD Dr. Fuchs)

9.30pm

Greeting

11.00am

  • Election sessions #3 (click on agenda item for more info)
  • Communication strategies for patients with different cultural and linguistic backgrounds (Dr. Ay)
  • Liquid Biopsy as Follow-Up - Ready for Primetime? (Prof. Loges + Prof. Bleckmann)
  • The basics of immunotherapy and the relevance for thoracic surgery (Prof. Passlick + Prof. Reinmuth)
  • A Discourse: Surgery and Systemic Therapy - Which Comes First? (Dr Welcker + Prof Hackanson)
  • Cancer Immunotherapy and Radiation - Additive or Toxic? (Prof. Rieken + PD Dr. Christoph)
  • Patient care in person versus digital - enrichment or competition? (Dr. Welslau + PD Dr. Fuchs)

9.30pm

Greeting

11.00am

  • Election sessions #3 (click on agenda item for more info)
  • Communication strategies for patients with different cultural and linguistic backgrounds (Dr. Ay)
  • Liquid Biopsy as Follow-Up - Ready for Primetime? (Prof. Loges + Prof. Bleckmann)
  • The basics of immunotherapy and the relevance for thoracic surgery (Prof. Passlick + Prof. Reinmuth)
  • A Discourse: Surgery and Systemic Therapy - Which Comes First? (Dr Welcker + Prof Hackanson)
  • Cancer Immunotherapy and Radiation - Additive or Toxic? (Prof. Rieken + PD Dr. Christoph)
  • Patient care in person versus digital - enrichment or competition? (Dr. Welslau + PD Dr. Fuchs)

9.30pm

Greeting

11.00am

  • Election sessions #3 (click on agenda item for more info)
  • Communication strategies for patients with different cultural and linguistic backgrounds (Dr. Ay)
  • Liquid Biopsy as Follow-Up - Ready for Primetime? (Prof. Loges + Prof. Bleckmann)
  • The basics of immunotherapy and the relevance for thoracic surgery (Prof. Passlick + Prof. Reinmuth)
  • A Discourse: Surgery and Systemic Therapy - Which Comes First? (Dr Welcker + Prof Hackanson)
  • Cancer Immunotherapy and Radiation - Additive or Toxic? (Prof. Rieken + PD Dr. Christoph)
  • Patient care in person versus digital - enrichment or competition? (Dr. Welslau + PD Dr. Fuchs)
Speakers
Related documents
Você tem certeza?
Restricted

Bookmarking is available only for logged-in users.

Registar Iniciar sessão